This looks like a fast compounder, not a moonshot. The core naval franchise already works, commercial nuclear services and components are scaling, and
special materials add another durable lane. That supports solid revenue growth and some multiple expansion from scarcity, but the stock should still trade below more speculative nuclear names because approvals, appropriations and project timing remain real throttles.